For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

AstraZeneca Pharma hits 52-week high on delisting plan

By Religare
|
AstraZeneca Pharma hits 52-week high on delisting plan
Shares of drug maker AstraZeneca Pharma India surged 20 per cent, hitting 52-week high, in early trade on Bombay Stock Exchange (BSE) on reports that parent company AstraZeneca Pharmaceuticals AB suggested that it plans to delist company's equity shares from the Indian stock exchanges.
 

Cheering the news, shares of company rallied as much as 20 per cent to trade at Rs 1110.90 a piece on the BSE.

In a similar fashion, shares of the company advanced 20 per cent to Rs 1,112.90 a piece on National Stock Exchange. Meanwhile, the broader benchmark Sensex was quoting at 21,100.07, down 20.05 points or 0.09 per cent at 9:45 hours.

Dion Global Solutions Ltd.

Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more